Maass H
Rontgenblatter. 1978 Jul;31(7):429-34.
Treatment of the metastasising mastocarcinoma is based on endocrinal and cytostatic treatment methods arranged systematically in parallel and in series. With endocrinal therapy alone, remission rates of around 30% are achieved, whereas with polychemotherapy the remission rates are 50 to 60%. For a large proportion of the patients, the systematic application of both methods leads to definite increase in life expectancy at a tolerable quality of life level. The determination of steroid hormone receptors in the tumorous tissue allows better selection of the patients and hence better on-target therapy.
转移性乳癌的治疗基于系统地并行和串行安排的内分泌和细胞抑制治疗方法。仅采用内分泌疗法，缓解率约为30%，而采用多药化疗时，缓解率为50%至60%。对于大部分患者而言，系统应用这两种方法可在可耐受的生活质量水平上显著延长预期寿命。测定肿瘤组织中的类固醇激素受体有助于更好地选择患者，从而实现更精准的靶向治疗。
